ASCO: Drug May Reactivate Chemo Effect in Ovarian CA

posted on Jun 09 by MedPage Today OB/Gyn in the Uncategorized category CHICAGO - Chemotherapy resistant ovarian cancer in genetically vulnerable women appears to regain its sensitivity after treatment with the PARP inhibitor olaparib, data from a small clinical study showed.